Clover Health is trading at $4.52 (-5.01%), with no clear company-specific announcement or catalyst explaining the August 10, 2026 decline.

  • The latest major event was August 5 earnings: Clover reported $28 million GAAP net income, strong membership growth, and raised full-year guidance; shares subsequently closed at $4.76 on August 7.
  • Clover is scheduled to present at the Canaccord Genuity Growth Conference on August 11, but no evidence directly links the event to the current drop.
  • Broader markets are only modestly weaker, so market sentiment alone does not clearly explain the move.